Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ProSight Global, Inc. | 102,504 | reported | 04 Aug 2021 | tx 24+614,296−692,851 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Aug 2021 | OTHER | ProSight Global, Inc. | 117,519 | 12.85 USD | |
| 04 Aug 2021 | OTHER | ProSight Global, Inc. | 44,664 | — | |
| 04 Aug 2021 | OTHER | ProSight Global, Inc. | 57,840 | — | |
| 04 Aug 2021 | OTHER | ProSight Global, Inc. | 20,714 | — | deriv |
| 04 Aug 2021 | OTHER | ProSight Global, Inc. | 333,659 | — | deriv |
| 25 Jul 2020 | EXERCISE | ProSight Global, Inc. | 5,892 | — | |
| 25 Jul 2020 | EXERCISE | ProSight Global, Inc. | 5,892 | — | deriv |
| 14 May 2020 | PURCHASE | ProSight Global, Inc. | 6,000 | 9.75 USD | |
| 13 May 2020 | PURCHASE | ProSight Global, Inc. | 266 | 9.95 USD | |
| 28 Feb 2020 | EXERCISE | ProSight Global, Inc. | 16,596 | — | |
| 28 Feb 2020 | GRANT_AWARD | ProSight Global, Inc. | 44,664 | — | |
| 28 Feb 2020 | TAX_WITHHOLDING | ProSight Global, Inc. | 19,088 | 13.40 USD | |
| 28 Feb 2020 | EXERCISE | ProSight Global, Inc. | 55,831 | — | |
| 28 Feb 2020 | TAX_WITHHOLDING | ProSight Global, Inc. | 5,650 | 13.40 USD | |
| 28 Feb 2020 | EXERCISE | ProSight Global, Inc. | 55,831 | — | deriv |
| 28 Feb 2020 | EXERCISE | ProSight Global, Inc. | 16,596 | — | deriv |
| 15 Nov 2019 | TAX_WITHHOLDING | ProSight Global, Inc. | 3,928 | 16.84 USD | |
| 15 Nov 2019 | EXERCISE | ProSight Global, Inc. | 11,470 | — | |
| 15 Nov 2019 | EXERCISE | ProSight Global, Inc. | 11,470 | — | deriv |
| 24 Jul 2019 | OTHER | ProSight Global, Inc. | 50,130 | — | |
| 24 Jul 2019 | GRANT_AWARD | ProSight Global, Inc. | 57,271 | — | deriv |
| 25 Jul 2019 | GRANT_AWARD | ProSight Global, Inc. | 125,000 | — | deriv |
| 25 Jul 2019 | GRANT_AWARD | ProSight Global, Inc. | 223,319 | — | deriv |
| 25 Jul 2019 | GRANT_AWARD | ProSight Global, Inc. | 17,857 | — | deriv |